Dyspnea Neuroscience Education on Patients With Chronic Obstructive Pulmonary Disease
Primary Purpose
Dyspnea
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Dyspnea Neuroscience education
Usual care
Sponsored by
About this trial
This is an interventional treatment trial for Dyspnea focused on measuring Education, Neuroscience education
Eligibility Criteria
Inclusion Criteria:
- Diagnostic of COPD by a physician or pneumologist
- Stage 1, 2 or 3 on the GOLD Classification
- GOLD Stage and FEV1 assessed by a physician in the last three months
- Access to a computer and internet
Exclusion Criteria:
- Cognitive impairment (MoCA-S score < 21)
- Depression disorder (PHQ-9 score ≥11)
- Generalized Anxiety Disorder (GAD-7 score ≥10)
- Instable comorbidities preventing physical activities
- Had a surgery in the past three months
- Had an exacerbation in the past three months
- Currently quitting tobacco
- Use of oxygenation
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Dyspnea Neuroscience education
Usual care
Arm Description
Outcomes
Primary Outcome Measures
Change from Perception of Dyspnea questionnaire at 4 and weeks and 6 months
Change from disability questionnaire at 4 and weeks and 6 months
Change from Quality of Life about respiratory disease questionnaire at 4 and weeks and 6 months
Change from Level of Physical Activity questionnaire at 4 and weeks and 6 months
Change from Activity-related intensity and unpleasantness of perceived dyspnea questionnaire at 4 and weeks and 6 months
Change from Self-efficacy Scale for Physical Activity questionnaire at 4 and weeks and 6 months
Secondary Outcome Measures
Change from Forced vital capacity physiological parameter at 4 and weeks and 6 months
Change from FEV1 physiological parameter at 4 and weeks and 6 months
Change from Six Minute Walk Test (Sp02% Change) physiological parameter at 4 and weeks and 6 months
Full Information
NCT ID
NCT04987125
First Posted
July 15, 2021
Last Updated
August 3, 2021
Sponsor
Cardenal Herrera University
1. Study Identification
Unique Protocol Identification Number
NCT04987125
Brief Title
Dyspnea Neuroscience Education on Patients With Chronic Obstructive Pulmonary Disease
Official Title
Dyspnea Neuroscience Education on Patients With Chronic Obstructive Pulmonary Disease
Study Type
Interventional
2. Study Status
Record Verification Date
August 2021
Overall Recruitment Status
Unknown status
Study Start Date
October 1, 2021 (Anticipated)
Primary Completion Date
April 1, 2022 (Anticipated)
Study Completion Date
May 1, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Cardenal Herrera University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The principal aim of this study was to adapt pain neuroscience education to dyspnea, Dyspnea Neuroscience Education (DNE), and measure its effect on dyspnea perception, physica l activity level, disability, quality of life and ventilatory and functional capacity through a randomized controlled trial. The secondary objectives were to evaluate its feasibility and its effect on emotional state (anxiety and depression), medical atten dance, number of exacerbations and the willingness to exercise.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dyspnea
Keywords
Education, Neuroscience education
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
40 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Dyspnea Neuroscience education
Arm Type
Experimental
Arm Title
Usual care
Arm Type
Active Comparator
Intervention Type
Behavioral
Intervention Name(s)
Dyspnea Neuroscience education
Intervention Description
Patients will follow an online therapeutic education course about dyspnea. Education about the cognitive and emotional aspects of dyspnea processing, with the goal of changing maladaptive cognitions and behaviors.
The course will be group-based (5 participants). The frequency will be of 1 session per week for 4 weeks, each session will have a duration of 1 hour.
Intervention Type
Behavioral
Intervention Name(s)
Usual care
Intervention Description
General health advice, physiotherapy treatment. The frequency will be of 1 session per week for 4 weeks, each session will have a duration of 1 hour.
Primary Outcome Measure Information:
Title
Change from Perception of Dyspnea questionnaire at 4 and weeks and 6 months
Time Frame
Preintervention, postintervention (4 weeks) and follow-up (6 months).
Title
Change from disability questionnaire at 4 and weeks and 6 months
Time Frame
Preintervention, postintervention (4 weeks) and follow-up (6 months).
Title
Change from Quality of Life about respiratory disease questionnaire at 4 and weeks and 6 months
Time Frame
Preintervention, postintervention (4 weeks) and follow-up (6 months).
Title
Change from Level of Physical Activity questionnaire at 4 and weeks and 6 months
Time Frame
Preintervention, postintervention (4 weeks) and follow-up (6 months).
Title
Change from Activity-related intensity and unpleasantness of perceived dyspnea questionnaire at 4 and weeks and 6 months
Time Frame
Preintervention, postintervention (4 weeks) and follow-up (6 months).
Title
Change from Self-efficacy Scale for Physical Activity questionnaire at 4 and weeks and 6 months
Time Frame
Preintervention, postintervention (4 weeks) and follow-up (6 months).
Secondary Outcome Measure Information:
Title
Change from Forced vital capacity physiological parameter at 4 and weeks and 6 months
Time Frame
Preintervention, postintervention (4 weeks) and follow-up (6 months).
Title
Change from FEV1 physiological parameter at 4 and weeks and 6 months
Time Frame
Preintervention, postintervention (4 weeks) and follow-up (6 months).
Title
Change from Six Minute Walk Test (Sp02% Change) physiological parameter at 4 and weeks and 6 months
Time Frame
Preintervention, postintervention (4 weeks) and follow-up (6 months).
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Diagnostic of COPD by a physician or pneumologist
Stage 1, 2 or 3 on the GOLD Classification
GOLD Stage and FEV1 assessed by a physician in the last three months
Access to a computer and internet
Exclusion Criteria:
Cognitive impairment (MoCA-S score < 21)
Depression disorder (PHQ-9 score ≥11)
Generalized Anxiety Disorder (GAD-7 score ≥10)
Instable comorbidities preventing physical activities
Had a surgery in the past three months
Had an exacerbation in the past three months
Currently quitting tobacco
Use of oxygenation
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Luis Suso-Martí, PhD
Phone
627819667
Email
luis.suso@gmail.com
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Dyspnea Neuroscience Education on Patients With Chronic Obstructive Pulmonary Disease
We'll reach out to this number within 24 hrs